regulatory affairs News
Most Popular regulatory affairs Story
C&L: Drakeman resigns from Medarex
Medarex CEO Donald Drakeman (photo) resigned his post as the company issued new findings in its investigation of how stock options were granted over the past 10 …
Read more...Latest Headlines
- November 7, 2006
- August 3, 2006
- March 28, 2006
- January 24, 2006
- November 15, 2005
- October 11, 2005
- September 25, 2005
- August 16, 2005
- June 20, 2005
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
